Ulrika Julku

5PUBLICATIONS
25CO-AUTHORS
Proteins and peptidesNeurology and neuromuscular diseasesBiomaterialsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2023
Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson's Disease.

Tommi P Kilpeläinen, Henri T Pätsi, Reinis Svarcbahs

|Apr 12, 2023
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.

Tony S Eteläinen, M Catarina Silva, Johanna K Uhari-Väänänen

|Jul 27, 2022
Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody.

Sahar Roshanbin, Ulrika Julku, Mengfei Xiong

|Feb 13, 2021
Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner.

Ulrika H Julku, Maria Jäntti, Reinis Svarcbahs

|Dec 09, 2016
Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.

Reinis Svarcbahs, Ulrika H Julku, Timo T Myöhänen

Pageof 1

Frequent Collaborators

4 joint publications

Timo T Myöhänen

2 joint publications

Tony S Eteläinen

2 joint publications

Maria Jäntti

2 joint publications

Hengjing Cui